CPT code 50382 identifies a percutaneous, image-guided removal and replacement of an indwelling ureteral stent. This interventional urology procedure is performed when transurethral access is not feasible or when percutaneous access is clinically indicated. The code matters nationally because it captures resource use, facility and professional components, and supports tracking of minimally invasive urinary tract interventions across acute care and outpatient settings.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for percutaneous stent exchange, typical sites of service, and payer coverage considerations. The publication summarizes national benchmarks for utilization and reimbursement patterns where available, highlights relevant billing and coding nuances for professional and facility claims, and outlines common clinical scenarios that prompt use of this code.

This summary serves clinicians, billing professionals, and policy analysts seeking an authoritative briefing on coding practice for percutaneous ureteral stent exchange. Data not available in the input is noted where applicable, and the content focuses on national implications rather than state-specific policies.